We came across a bullish thesis on Sellas Life Sciences Group Inc (SLS) on ValueInvestorsClub by ContraMundem. In this article we will summarize the bulls’ thesis on SLS. Sellas Life Sciences shares were trading at $1.45 when this thesis was published, vs. closing price of $1.26 on Sep 17.
A laboratory technician researching a sample of cells in a biotechnology laboratory.
Sellas Life Sciences (SLS) is a biotech company making waves in the cancer treatment arena with its promising pipeline...